Crispr « Search Results « Science and Enterprise

Crispr Heart Disease Start-Up Raises New $63M

By Alan, on June 11th, 2020%

A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round. . . . → Read More: Crispr Heart Disease Start-Up Raises New $63M

Biotechs Apply Crispr Gene-Editing for Hemophilia

By Alan, on June 1st, 2020%

A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal. . . . → Read More: Biotechs Apply Crispr Gene-Editing for Hemophilia

GSK, Biotech Partner on Crispr Covid-19 Test

By Alan, on May 21st, 2020%

A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline. . . . → Read More: GSK, Biotech Partner on Crispr Covid-19 Test

[Updated] Fast Paper Strip Covid-19 Test Devised with Crispr

By Alan, on May 6th, 2020%

A simple, fast test for Covid-19 infections with treated paper dipped in specimens is being created with the gene-editing technology Crispr. . . . → Read More: [Updated] Fast Paper Strip Covid-19 Test Devised with Crispr

Patient Receives First Crispr Genetic Eye Treatment

By Alan, on March 4th, 2020%

An individual with a rare genetic eye disease received the first dose of an edited gene in a clinical trial of an experimental treatment for the disorder. . . . → Read More: Patient Receives First Crispr Genetic Eye Treatment

Crispr Company Raises $45M in Venture Funds

By Alan, on January 31st, 2020%

A spin-off enterprise from a pioneering Crispr research lab is raising $45 million in venture funds to develop diagnostics and other applications. . . . → Read More: Crispr Company Raises $45M in Venture Funds

Trial Underway Testing Crispr-Based Antibiotic

By Alan, on January 8th, 2020%

A clinical trial is recruiting participants to test an antibiotic made with engineered viruses, in people threatened with urinary tract infections from E. coli bacteria. . . . → Read More: Trial Underway Testing Crispr-Based Antibiotic

Broad Inst, Biotech Partner on Immune-Safe Crispr

By Alan, on December 3rd, 2019%

A company designing synthetic proteins and the Broad Institute are developing ways to reduce the threat of edited genes producing an immune-system response. . . . → Read More: Broad Inst, Biotech Partner on Immune-Safe Crispr

First Blood Disorder Crispr Treatments Reported

By Alan, on November 19th, 2019%

Early results from a clinical trial testing gene editing treatments for inherited blood disorders show the treatments helped patients improve their conditions. . . . → Read More: First Blood Disorder Crispr Treatments Reported

Nanotech Crispr Delivery in Development

By Alan, on October 2nd, 2019%

Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment. . . . → Read More: Nanotech Crispr Delivery in Development

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise